International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Special Issue 3 doi: 10.5281/zenodo.8077898
Original Article
Ginko biloba: Constituent and Activity in the Treatment of Different Diseases
 ,
 ,
 ,
 ,
 ,
Published
June 25, 2023
Abstract

Ginkgobiloba is an ancient plant species that is thought to provide a variety of health benefits to living organisms and contains plenty of bioactive components, making it a chemically diversified plant. G. biloba has been shown to have a variety of medicinal and pharmacological properties, including anticancer, antidementia, antidiabetic,antiobesity, antilipidemic, antimicrobial, antioxidant, antilipid peroxidation, antiplatelet, anti-inflammatory, hepatoprotective, antidepressant, antiaging, immunomodulatory, antihypertensive, and neuroprotective effects and is frequently used to treat neurological, cardiovascular, and respiratorydiseases, such as tardive dyskinesia. So this review is all about to describe the therapeutic action and potency of Ginkgo biloba. A 2012 meta-analysis did not find support for the use of Ginkgo biloba in enhancing cognitive function in healthy adults. EGb has been shown to reduce the oxidative stress of cardiomyocytes in animal models of myocardial injury , atherosclerosis , hypertension by kidney damage , as well as in animals and human subjects with metabolic syndrome. The cardiovascular response to Ginkgo biloba is practically irrelevant in normotensive animals, confirming ex vivo studies. A treatment course of Ginkgo biloba 120 or 240 mg daily for 3 months, resulted in a significant decrease in diastolic blood pressure in the low-dose group.

Recommended Articles
Loading Image...
Volume-4, Special Issue 3
Citations
217 Views
4 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved